Peter Radovich is President & COO at Mirum Pharmaceuticals, Inc. (MIRM). They have made 20 open-market trades across 2 companies since 2015, most recently 2026-06-05.
CIK 0001650131
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $250K since 2015, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MIRM | 57,260 | $4.6M |
| GBT | 9,627 | $659K |
| RAIN | 8,796 | $5K |
| Total | $5.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIRM | SELL | 2026-03-16 | 2026-03-17 | $91.98 | $3.0M | -7.1% | +0.7% | +6.2% |
| MIRM | SELL | 2026-02-02 | 2026-02-03 | $103.30 | $272K | -2.5% | -16.9% | -0.0% |
| MIRM | SELL | 2026-01-26 | 2026-01-27 | $96.19 | $302K | -1.0% | -9.2% | -8.9% |
| MIRM | SELL | 2026-01-22 | 2026-01-23 | $93.33 | $222K | +8.1% | +10.1% | -4.4% |
| MIRM | SELL | 2025-03-17 | 2025-03-18 | $44.21 | $697K | +4.3% | -11.3% | +14.4% |
| MIRM | SELL | 2025-03-04 | 2025-03-05 | $45.58 | $1.4M | +2.9% | -4.2% | +3.2% |
| MIRM | SELL | 2025-02-03 | 2025-02-04 | $48.22 | $253K | -0.7% | -13.8% | -12.4% |
| MIRM | SELL | 2025-01-24 | 2025-01-27 | $47.92 | $304K | +5.8% | +4.3% | -14.7% |
| MIRM | SELL | 2025-01-07 | 2025-01-08 | $42.82 | $171K | +12.8% | +23.3% | -5.0% |
| MIRM | SELL | 2024-03-25 | 2024-03-25 | $25.80 | $222K | +0.0% | -8.5% | +32.8% |
| MIRM | SELL | 2024-02-02 | 2024-02-05 | $26.19 | $47K | +10.5% | +8.4% | +0.6% |
| MIRM | SELL | 2024-01-08 | 2024-01-09 | $28.03 | $39K | -3.9% | -1.9% | -5.8% |
| MIRM | SELL | 2023-07-03 | 2023-07-05 | $25.65 | $37K | +5.4% | +2.8% | +15.7% |
| MIRM | SELL | 2023-01-09 | 2024-03-18 | $20.62 | $28K | -5.6% | -10.4% | +24.0% |
| MIRM | SELL | 2021-10-01 | 2021-10-01 | $19.26 | $26K | -12.1% | -15.6% | -18.3% |
| GBT | SELL · 10b5-1 | 2018-02-01 | 2018-02-02 | $57.30 | $47K | +4.1% | +2.2% | -27.6% |
| GBT | SELL | 2018-01-23 | 2018-01-25 | $60.00 | $1.8M | -4.0% | +3.6% | -26.1% |
| GBT | SELL | 2018-01-10 | 2018-01-11 | $50.00 | $750K | +3.6% | +6.8% | -19.8% |
| GBT | SELL | 2017-10-30 | 2017-10-31 | $35.00 | $438K | -4.2% | -1.7% | +55.3% |
| GBT | SELL | 2017-08-31 | 2017-09-05 | $30.00 | $72K | -2.1% | +12.9% | +39.0% |
| GBT | BUY | 2015-08-17 | 2016-01-07 | $20.00 | $250K | -11.6% | -34.3% | -9.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.